CAS 879127-16-9: Cyclopropanecarboxamide,N-[3-[[4-[[3-(trifluoromethyl)phenyl]amino]-2-pyrimidinyl]amino]phenyl]-

Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) is a potent inhibitor of Aurora A kinase (IC50 = 42 nM).1 It is selective for Aurora A over BMX, BTK,

Aurora kinase inhibitor-3

N-{3-[(4-{[3-(Trifluoromethyl)phenyl]amino}-2-pyrimidinyl)amino]phenyl}cyclopropanecarboxamide is a drug that belongs to the class of inhibitor drugs. It inhibits the enzyme histone deacetylase (HDAC), which regulates gene expression. This compound has been shown to inhibit tumor growth in mouse models of prostate cancer by targeting HDAC and preventing cancer cells from dividing. N-{3-[(4-{[3-(Trifluoromethyl)phenyl]amino}-2-pyrimidinyl)amino]phenyl}cyclopropanecarboxamide has also been shown to inhibit the growth of colon cancer cells and leukemia cells in vitro, as well as human breast cancer cells in vivo. The inhibition of HDAC leads to an increase in acetylation at the promoter regions, resulting in increased

N-(3-((4-((3-(Trifluoromethyl)Phenyl)Amino)Pyrimidin-2-Yl)Amino)Phenyl)Cyclopropanecarboxamide